Breast Implant–Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The association between breast implants and breast implant associated anaplastic large cell lymphoma (BIA-ALCL), has been confirmed. Implant related risk has been difficult to estimate due to incomplete or unknown implant histories and lack of clarity on the number of implants utilized.

Related collections

Most cited references 15

Record: found
Abstract: found
Article: not found

Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma.

Mark W. Clemens, L. Jeffrey Medeiros, Charles Butler … (2016)

Breast implant-associated anaplastic large-cell lymphoma (BI-ALCL) is a rare type of T-cell lymphoma that arises around breast implants. The optimal management of this disease has not been established. The goal of this study is to evaluate the efficacy of different therapies used in patients with BI-ALCL to determine an optimal treatment approach.

0 comments Cited 140 times – based on 0 reviews      Review now

Record: found
Abstract: found
Article: not found

Anaplastic large cell lymphoma occurring in women with breast implants: analysis of 173 cases.

Garry S Brody, Dennis Deapen, Clive R Taylor … (2015)

The first silicone breast implant was inserted in 1962. In 1997, the first case of anaplastic large cell lymphoma (ALCL) in association with a silicone breast implant was reported. The authors reviewed 37 articles in the world literature reporting on 79 patients and collected another 94 unreported cases as of the date of submission. The world literature was reviewed. Missing clinical and laboratory information was solicited from the authors and treating physicians. As several different specialties were involved, information was not in one place. Many (but not all) authors and treating physicians were responsive, resulting in incomplete data. ALCL lesions first presented as late peri-implant seromas, a mass attached to the capsule, tumor erosion through the skin, in a regional node, or discovered during revision surgery. The clinical course varied widely from a single positive cytology result followed by apparent spontaneous resolution, to disseminated treatment-resistant tumor and death. There was no preference for saline or silicone fill or for cosmetic or reconstructive indications. Where implant history was known, the patient had received at least one textured-surface device. Extracapsular dissemination occurred in 18 cases; nine of those were fatal. Histochemical markers were primarily CD-30 and Alk-1. Other markers occurred at a lower frequency. Risk estimates ranged from one in 500,000 to one in 3 million women with implants. Breast implant-associated ALCL is a novel manifestation of site- and material-specific lymphoma originating in a specific scar location, presenting a wide array of diverse characteristics and suggesting a multifactorial cause.

0 comments Cited 126 times – based on 0 reviews      Review now

Record: found
Abstract: found
Article: not found

Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma.

Honghua Hu, Anita Jacombs, Karen Vickery … (2015)

Biofilm infection of breast implants significantly potentiates capsular contracture. This study investigated whether chronic biofilm infection could promote T-cell hyperplasia.

0 comments Cited 89 times – based on 0 reviews      Review now

All references

Author and article information

Journal

Title: Plastic and Reconstructive Surgery

Abbreviated Title: Plastic and Reconstructive Surgery

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Print): 0032-1052

Publication date Created: 2017

Publication date (Print): October 2017

Volume: 140

Issue: 4

Pages: 645-654

Article

DOI: 10.1097/PRS.0000000000003654

PubMed ID: 28481803

SO-VID: 60d3dced-ebdf-4eb2-a251-404b7546e3c5

History

Data availability:

Comments

Comment on this article

Cited by 114

See all cited by

Most referenced authors 233

See all reference authors

- Version 1

Breast Implant–Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand : High-Surface-Area Textured Implants Are Associated with Increased Risk

Read this article at